Arthritis Research & Therapy

official impact factor 4.36
Search for
Advanced search
Arthritis Research & Therapy
Tools
Share this article

This article is part of the supplement: Targeting B cells in autoimmune diseases

Highly Access

Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis

John D Hainsworth

Arthritis Res Ther 2003, 5(Suppl 4):S12-S16 doi:10.1186/ar1008

Accesses  

  • Last 30 days: 28 accesses
  • Last 365 days: 460 accesses
  • All time: 9449 accesses

Cited by

BioMed Central: 1 citation

Research article   Open Access

Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody

Anne-Sophie Rouzière, Christian Kneitz, Arumugam Palanichamy, Thomas Dörner, Hans-Peter Tony Arthritis Research & Therapy 2005, 7:R714-R724 (1 April 2005)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Google Scholar: View citations

PubMed Central: View citations